VeriChip is the company that is pioneering commercial microchip implants in people in the United States. Starting off as Digital Angel in November 2001, the company played around with an array of “wearables” – which are microchip-fitted devices, used in various applications. From serving as ultra portable computers, to the monitoring of blood pressure and other medical data in the wearer. The outputs can be fed directly via satellite to remote locations, for instance a hospital, where it can be monitored. Soon ,the wearables, despite assurances by Digital Angel that it had no such intentions, were re-introduced as microchip implants to be embedded within people’s skin. Many were shocked at the incredible speed at which the new product secured the mandatory Food and Drugs Agency approval, which later became understandable when the Secretary of Health at the time of this decision, Tommy Thomson, resigned to become a member of VeriChip’s Board (see ref, also CA! Vol 10 No 5)
Regular readers of CA! will be familiar with the various hypes that Mr Scott Silverman’s company, VeriChip, tried to use to convince the world that they needed a microchip implant very badly. From VeriGuard (to protect you from kidnappers – i.e. your location can be traced, provided the limb bearing the chip is left intact by the kidnappers!), VeriMed (which promises to make people’s medical records available so their physicians can set to work immediately they are brought in from some emergency situation that could possibly, thus saving precious seconds – hmm!), etc, etc (see Vol 7 No 1).
Needless to say, the products were big flops. Not only are people uncomfortable with having themselves tagged and thereby subject to 24/7 surveillance, it was further revealed in 2007 that the implanted chip could be linked with the inducement of cancer in animals. (See CA! Vol 10 No 5). Moreover, for every touted benefit, there existed dozens of other proven, more effective and far simpler solutions!
The biggest success for the product so far seems to be the microchipping (between 2007 – 2009) of about 200 Alzheimer subjects who were made available by a nursing home in West Palm Beach. Even that event raised considerable hoopla as the study was not subjected to any review by any ethic committee, and many of the senior citizens involved were incapacitated and not in any position to make informed decision about participating or not. Moreover, it was revealed that the microchip company had sponsored the nursing home, the Alzheimer’s Community Care, in fundraisers before.
All the failings of the company VeriChip naturally translates to financial woes. As members of the company’s board threw in the towel one by one, it was the passion and money of the CEO, Mr Scott Silverman, that has been keeping the company floating. (Apparently, the man understands very well that some things in life are far more important than the financial profit associated with them!) And part of the never-ending restructuring is the emergence of the new company, PositiveID, born November 11 2009 (see its Annual Report in the mandatory 10-Q form with the US Security and Exchanges Commission at www.faqs.org/sec-filings/100319/VeriChip-CORP_10-K/). In forming PostiveID, Verichip had been merged with Steel Vault (also largely owned by Mr Silverman), a company which is into credit monitoring and identity-theft prevention.
Of course, Mr Silverman would be hoping that the changes in name might make people lose track or interest in the company’s deadly and dubious products.
Although the company is still losing money and, at least according to its 10-Q form, has no hope of a turn around in the near future, Mr Silverman is nevertheless building strategic alliances which continue to seek to establish microchip implants in vital sectors of society. In volume 12 No 5, we drew attention to the fact that the new Obama health care initiative might be attempting to provide a massive bail-out for PositiveID by assigning the chip a central role in the new system – basically for record keeping. However, we are not sure at the moment how the product features in the final version of the bill as eventually approved. However, that more governments of the world are interested in promoting Mr Silverman’s product seems evident considering that exactly the same idea is being touted in Australia’s on-going HealthCare reform package. Even the technical specifications looked like a direct copy from PositiveID’s manual (http://industry.bnet.com/pharma/10007874/conspiracy-theory-how-16-digits-linked-australian-medicare-to-positiveid-chip-implants/).
Strategic alliances already forged in the private sector that seems to guarantee the continued sustenance of the PositiveID’s dream include:
A partnership with a Minnesota firm called Receptors to develop the “iGlucose system” in which the microchip automatically and continuously communicate blood sugar readings to an online database. The company envisions integrating its iGlucose system and its other rapid testing devices so that all test results could be automatically downloaded into a patient’s online personal health record. According to Mr Silverman, “In theory, way down the road, that same chip could contain a device to release insulin as well.” PositiveID further hopes to use similar technology to create a non-implantable test kit that could quickly identify various flu strains. This it hopes to accomplish before the next flu season. (www.floridatrend.com/article.asp?page=1&aID=53177)
In another strategic alliance with Innovations Avocare, the onlined medical records system in Florida’s various regional healthcare organizations can now be integrated with PositiveID’s Health Link. This brings, in a jiffy, more than 1 million patients into the Company’s sphere of business.
The Health Link electronic medical record service which PositiveID is already offering for businesses “on a paid subscription basis” provides access to a patient’s online medical records. It can be used with an implanted microchip and linked to Microsoft (MSFT)’s HealthVault and Google (GOOG) Health. Later on, the company intends to offer on the same platform various identification tools and technologies for consumer establishments and businesses. To pull this off, PositiveID is partnering with Boston-based FIS, a provider of technology to the banking industry.
Commenting on these developments, the news agency BNET feels that “The PositiveID/Avocare alliance will doubtless be painted by critics as a sinister development in which Americans’ medical privacy will end up becoming the online plaything of PositiveID, and that life in the U.S. will become difficult for those who do not want a chip inside them (in much the same way as it is currently difficult for anyone without a credit card, cellphone, email address or internet access).” (http://www.bnet.com/blog/drug-business/positiveid-deal-advances-use-of-microchip-implants-in-florida-health-system/3647)
CA! believes the mark of the beast will be a form of microchip implant. We have previously shown how such a chip gives remote access to your soul (via your mind) with dire eternal consequences (see vol 4 No 6, Vol 7 No 1). However, we believe that the chips of the Silvermans currently in the marketplace, while interesting to follow, are nothing but mere distractions from the real chip. For instance, knowledge about the Multiple Micro Electrode Array (MMEA) which comprises an array of about 100 microchips (developed by combination of Kevin Warwick and US DARPA, see Vol 11 No 4) is already in the public domain. Without doubts, more sophisticated ones, classified at the moment, and perhaps years ahead of even the MMEA exist somewhere in the closet of the world’s secret services. It would appear then that the main job for Mr Silverman and company is to continually guage and mould public attitude to microchip implants, as well as get the chip integrated into vital sectors within civil society. Even if it takes the next generation to accept it, it is important to them that they keep alive the rhetorics and efforts. The real mark of the beast could well be ready for deployment, awaiting the right socio-economic conditions – which in our opinion eventually depend on the Lord’s agenda and time-table, known only to Him. Once chips-under-the-skin has become accepted and fashionable, few will note the difference when the verichips are switched with MMEAs. For efforts in promoting microchip implants in other countries outside the US, see CA! Vol 12 No 5.